Analysen von Mark Purcell
28.10.21 | Sanofi Overweight | Morgan Stanley | |
17.09.21 | AstraZeneca Overweight | Morgan Stanley | |
17.09.21 | MorphoSys Overweight | Morgan Stanley | |
17.09.21 | Bayer Overweight | Morgan Stanley | |
27.07.21 | Novartis Overweight | Morgan Stanley | |
26.01.21 | Novartis overweight | Morgan Stanley | |
08.01.21 | Sanofi overweight | Morgan Stanley | |
08.01.21 | Novartis overweight | Morgan Stanley | |
Werbung
|
|||
08.01.21 | Bayer overweight | Morgan Stanley | |
07.12.20 | AstraZeneca overweight | Morgan Stanley | |
21.10.20 | Novartis overweight | Morgan Stanley | |
14.09.20 | Bayer overweight | Morgan Stanley | |
01.09.20 | Novartis overweight | Morgan Stanley | |
10.08.20 | Bayer overweight | Morgan Stanley | |
10.08.20 | Roche overweight | Morgan Stanley | |
28.07.20 | Roche overweight | Morgan Stanley | |
25.06.20 | Bayer overweight | Morgan Stanley | |
09.06.20 | Sanofi overweight | Morgan Stanley | |
27.04.20 | Roche overweight | Morgan Stanley | |
22.04.20 | Bayer overweight | Morgan Stanley | |
03.03.20 | Roche overweight | Morgan Stanley | |
18.02.20 | Roche overweight | Morgan Stanley | |
04.02.20 | Sanofi overweight | Morgan Stanley | |
06.01.20 | Bayer overweight | Morgan Stanley | |
06.01.20 | Roche overweight | Morgan Stanley | |
06.01.20 | Sanofi overweight | Morgan Stanley | |
17.10.19 | Roche overweight | Morgan Stanley | |
16.10.19 | Roche overweight | Morgan Stanley | |
23.09.19 | Sanofi overweight | Morgan Stanley | |
30.04.19 | Roche overweight | Morgan Stanley | |
11.02.19 | Roche overweight | Morgan Stanley | |
14.12.18 | Roche overweight | Morgan Stanley | |
05.05.15 | GSK overweight | Barclays Capital | |
01.04.15 | GSK overweight | Barclays Capital | |
01.04.15 | Roche overweight | Barclays Capital | |
16.01.15 | GSK kaufen | Barclays Capital | |
16.01.15 | Roche overweight | Barclays Capital | |
16.10.14 | Sanofi overweight | Barclays Capital | |
15.10.14 | Roche overweight | Barclays Capital | |
25.07.14 | Roche overweight | Barclays Capital | |
16.04.14 | Roche overweight | Barclays Capital | |
10.03.14 | Sanofi overweight | Barclays Capital | |
10.03.14 | Roche overweight | Barclays Capital | |
28.07.11 | GSK overweight | Barclays Capital |